Budoeez LS
Composition: Each 2 mL respule contains: Levosalbutamol Hydrochloride IP Equivalent to Levosalbutamol 1.25 mg Budesonide – 0.5 mg Water for Injections IP – q.s. Dosage Form: Inhalation Suspension Strength: 1.25 mg + 0.5 mg / 2 mL Route: Inhalation by nebulization Formulation: Preservative-Free Pack Size: 4 × 5 × 2 mL Respules
BUDOEEZ LS Respules is a preservative-free inhalation suspension combining Levosalbutamol 1.25 mg and Budesonide 0.5 mg per 2 mL. It combines a bronchodilator with an inhaled corticosteroid to address two important components of obstructive airway disease: bronchoconstriction and airway inflammation.
Levosalbutamol provides β₂-adrenergic bronchodilation, while Budesonide provides local anti-inflammatory activity in the airways. The combination is intended for physician-directed nebulization therapy when both bronchodilator and inhaled corticosteroid treatment are clinically appropriate. Indian guidance on nebulization recognizes levosalbutamol + budesonide among inhaled corticosteroid/bronchodilator combinations available for nebulization in obstructive airway disease.
Overview
BUDOEEZ LS combines Levosalbutamol and Budesonide in a convenient 2 mL nebulizer suspension.
Levosalbutamol is a selective β₂-adrenergic agonist that promotes relaxation of bronchial smooth muscle and helps relieve bronchoconstriction. Budesonide is an inhaled corticosteroid that reduces airway inflammatory activity and helps control airway inflammation.
By combining bronchodilator and anti-inflammatory actions, BUDOEEZ LS provides a two-pronged pharmacological approach for patients in whom both components of therapy are clinically indicated.
Clinical Positioning
BUDOEEZ LS → Bronchodilation + Anti-inflammatory Action
Levosalbutamol 1.25 mg + Budesonide 0.5 mg / 2 mL
Key Benefits
Dual-Component Respiratory Therapy
Combines a bronchodilator and inhaled corticosteroid in a single nebulization formulation.
Bronchodilator Action
Levosalbutamol stimulates β₂-adrenergic receptors in bronchial smooth muscle, promoting bronchodilation and helping relieve bronchoconstriction.
Anti-Inflammatory Action
Budesonide acts locally in the airways to reduce inflammatory activity and airway hyperresponsiveness. Inhaled corticosteroids are established controller therapy for asthma.
Addresses Two Key Components
BUDOEEZ LS provides pharmacological activity directed toward both airway narrowing and airway inflammation.
Preservative-Free Formulation
The product is supplied as a preservative-free inhalation suspension, as indicated on the pack.
Convenient Unit-Dose Respules
Each 2 mL respule contains a measured quantity of the combination for nebulization.
Suitable for Nebulized Therapy
Provides the combination in a dosage form designed specifically for administration through a nebulizer.
Indications / Uses
BUDOEEZ LS may be prescribed for:
- Obstructive airway conditions associated with bronchoconstriction and airway inflammation
- Asthma management where both bronchodilator and inhaled corticosteroid therapy are clinically appropriate
- Physician-directed nebulization therapy requiring combined Levosalbutamol + Budesonide
- Situations where nebulized delivery of both therapeutic components is considered appropriate
Indian guidance on nebulization therapy lists levosalbutamol + budesonide among inhaled corticosteroid/bronchodilator combinations available for nebulization in obstructive airway disease.
Use should be based on the treating physician's clinical assessment and applicable prescribing information.